A reduction in TRIM11 protein levels has been reported in Alzheimer's disease (AD) brains, and TRIM11 has been suggested to play a role in the SUMOylation of mutant tau as well as excess normal tau and its subsequent degradation by proteasomes. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.